Inventaire - your friends and communities are your best library - Inventaire

PET/Computed Tomography in Renal, Bladder, and Testicular Cancer

published in: PET clinics

date of publication: 2015-04-24

main subject: tomography, computed tomography

Cites articles 82

Date

Title

Authors

2015-01-01

11C-choline PET/CT for restaging of bladder cancer

Francesco Ceci, Stefano Fanti
2015-01-01

Proposal of a new acquisition protocol for bladder cancer visualization with 18F-FDG PET/CT.

Domenico Rubello, Maria Cristina Marzola, Sotirios Chondrogiannis
2014-07-10

The role of fluorine-18-fluorodeoxyglucose positron emission tomography in evaluating the response to tyrosine-kinase inhibitors in patients with metastatic primary renal cell carcinoma

Barbara Muoio, Giorgio Treglia
2014-05-15

Diagnostic performance of fluorine-18-fluorodeoxyglucose positron emission tomography in the postchemotherapy management of patients with seminoma: systematic review and meta-analysis

Giorgio Treglia, Ramin Sadeghi, Salvatore Annunziata, Carmelo Caldarella, Francesco Bertagna
2014-05

Frontiers in clinical and molecular diagnostics and staging of metastatic clear cell renal cell carcinoma

Wojciech Kukwa, Anna M Czarnecka, Cezary Szczylik, Anna Kornakiewicz
2014-06-03

Radiological evaluation of response to treatment: application to metastatic renal cancers receiving anti-angiogenic treatment

Charles A. Cuenod, Laure S. Fournier
2014-06-06

Volumetric FDG-PET predicts overall and progression- free survival after 14 days of targeted therapy in metastatic renal cell carcinoma
2014-06-04

Diagnostic accuracy of integrated (18)F-FDG PET/CT for restaging patients with malignant germ cell tumours

Sellam Karunanithi
2014-06-02

The early response of renal cell carcinoma to tyrosine kinase inhibitors evaluated by FDG PET/CT was not influenced by metastatic organ

Tomio Inoue, Noboru Nakaigawa
2014-03-07

Pairwise comparison of 89Zr- and 124I-labeled cG250 based on positron emission tomography imaging and nonlinear immunokinetic modeling: in vivo carbonic anhydrase IX receptor binding and internalization in mouse xenografts of clear-cell renal cell carcinoma

Joseph R Osborne, Jason S. Lewis, S M Larson, Pat Zanzonico, Sarah M Cheal
2014-03-01

Imaging management of incidentally detected small renal masses
2014-07-09

Prognostic value of 11C-choline PET/CT and CT for predicting survival of bladder cancer patients treated with radical cystectomy

Bernhard Haller, Tobias Maurer, Markus Schwaiger, Michael Souvatzoglou
2014-02-01

18F-fluorodeoxyglucose--positron emission tomography/computed tomography aids staging and predicts mortality in patients with muscle-invasive bladder cancer

Nathan Lawrentschuk, Andrew M Scott, Rustom Manecksha
2014-05-01

Diagnostic accuracy of (11)C-choline PET/CT in preoperative lymph node staging of bladder cancer: a systematic comparison with contrast-enhanced CT and histologic findings

Anna Margherita Maffione, Francesco Ceci, Marco Borghesi, Stefano Fanti
2014-03-01

Diagnosis of complex renal cystic masses and solid renal lesions using PET imaging: comparison of 11C-acetate and 18F-FDG PET imaging.

Hidehiko Okazawa
2014-09-01

Tumor thrombus: ancillary findings on FDG PET/CT in an oncologic population

Søren Hess, Abass Alavi, Mudalsha Ravina
2013-12-10

Is The Value of FDG PET/CT In Evaluating Renal Metastasis Underestimated? A Case Report And Review of The Literature

Tanju Yusuf Erdil
2013-07-10

FDG-PET as a predictive biomarker for therapy with everolimus in metastatic renal cell cancer
2013-08-01

Comparison of 18F fluoride PET/CT and 99mTc-MDP bone scan in the detection of skeletal metastases in urinary bladder carcinoma
2013-12-12

EAU guidelines on muscle-invasive and metastatic bladder cancer: summary of the 2013 guidelines

María J. Ribal, Amir Sherif
2013-11-22

18F-FDG PET/CT impact on testicular tumours clinical management

Valentina Ambrosini, Stefano Fanti
2013-08-08

Is fluorine-18 fluorodeoxyglucose positron emission tomography useful for detecting bladder lesions? A meta-analysis of the literature
2013-07-23

18F-Fluoride PET/CT in the detection of bone metastases in clear cell renal cell carcinoma: discordance with bone scintigraphy

Raffaella Palumbo, Daniela D'Ambrosio
2013-07-02

Prognostic implication of extrarenal metabolic tumor burden in advanced renal cell carcinoma treated with targeted therapy after nephrectomy

June-Key Chung
2013-06-24

Impact of (18) F-fluorodeoxyglucose (FDG)-positron-emission tomography/computed tomography (PET/CT) on management of patients with carcinoma invading bladder muscle.
2013-06-01

18F-FDG-PET/CT in potentially advanced renal cell carcinoma: a role in treatment decisions and prognosis estimation
2013-05-18

Balancing process and risk: standardizing posttreatment surveillance for renal cell carcinoma
2012-07-01

PET/CT and MRI in Bladder Cancer

Baris Turkbey, Peter L Choyke, Kirsten Bouchelouche
2012-12-03

Positron emission tomography/computed tomography identification of clear cell renal cell carcinoma: results from the REDECT trial

Jorge A. Carrasquillo
2012-06-08

Spectrum of malignant renal and urinary bladder tumors on 18F-FDG PET/CT: a pictorial essay
2012-07-31

Prospective evaluation of MRI, ¹¹C-acetate PET/CT and contrast-enhanced CT for staging of bladder cancer

Oğuz Akın, Hedvig Hricak, Bernard H Bochner, Hebert Alberto Vargas
2012-06-01

A systematic review of neoadjuvant and adjuvant chemotherapy for muscle-invasive bladder cancer

Article - wd:Q35776939

Welcome to Inventaire

the library of your friends and communities

you are offline